Literature DB >> 9288832

HIV-1 envelope glycoprotein 120 regulates brain IL-1beta system and TNF-alpha mRNAs in vivo.

S E Ilyin1, C R Plata-Salamán.   

Abstract

Human immunodeficiency virus type I (HIV-1)-derived envelope glycoprotein 120 (gp120) is proposed to play an important role in HIV-1 neuropathology. Gp120 may act through mediators including proinflammatory cytokines. Here, we investigated the regulation of the IL-1beta system [IL-1beta, IL-1 receptor type I (IL-1RI), IL-1 receptor antagonist (IL-1Ra)], TNF-alpha and TGF-alpha mRNAs in the rat central nervous system (CNS) in response to the constant intracerebroventricular (ICV) microinfusion of HIV-1 gp120 for 72 h and 144 h. The results show that gp120: (1) increased IL-1beta and IL-1Ra mRNAs levels in the same samples from the cerebellum, hypothalamus and midbrain, with the largest increase in the hypothalamus; (2) induced profiles of IL-1beta mRNA and IL-1Ra mRNA that were highly intercorrelated; (3) increased the hypothalamic TNF-alpha mRNA levels; and (4) did not affect the IL-1RI mRNA and TGF-alpha mRNA levels in any brain region. A dysregulation in the IL-1beta/IL-1Ra CNS balance and a mutual induction and synergistic activity of IL-1beta and TNF-alpha could result in a deleterious amplification cycle of cellular activation and cytotoxicity with implications to HIV-1-associated encephalitis, encephalopathy, and neurological manifestations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288832     DOI: 10.1016/s0361-9230(97)00091-9

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

1.  Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss.

Authors:  Hee Jung Kim; Angela H Shin; Stanley A Thayer
Journal:  Mol Pharmacol       Date:  2011-06-13       Impact factor: 4.436

Review 2.  Glucocorticoids and central nervous system inflammation.

Authors:  Klaus Dinkel; William O Ogle; Robert M Sapolsky
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  Human immunodeficiency virus glycoprotein 160 induces cytokine mRNA expression in the rat central nervous system.

Authors:  C Gemma; E M Smith; T K Hughes; M R Opp
Journal:  Cell Mol Neurobiol       Date:  2000-08       Impact factor: 5.046

4.  Protection of human cerebral neurons from neurodegenerative insults by gene delivery of soluble tumor necrosis factor p75 receptor.

Authors:  Marc Adrian Williams; Jadwiga Turchan; Yang Lu; Avindra Nath; Daniel B Drachman
Journal:  Exp Brain Res       Date:  2005-04-13       Impact factor: 1.972

5.  Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS.

Authors:  Dima A Hammoud; Christopher J Endres; Ankit R Chander; Tomas R Guilarte; Dean F Wong; Ned C Sacktor; Justin C McArthur; Martin G Pomper
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

6.  HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death.

Authors:  M T Corasaniti; A Bilotta; M C Strongoli; M Navarra; G Bagetta; G Di Renzo
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

7.  Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection.

Authors:  Aaron Christensen-Quick; Mark Lafferty; Lingling Sun; Luigi Marchionni; Anthony DeVico; Alfredo Garzino-Demo
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

8.  Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats.

Authors:  Wenwen Zheng; Handong Ouyang; Xuexing Zheng; Shue Liu; Marina Mata; David J Fink; Shuanglin Hao
Journal:  Mol Pain       Date:  2011-05-20       Impact factor: 3.395

Review 9.  Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta.

Authors:  Valerio Taggi; Mario Riera Romo; Micheline Piquette-Miller; Henriette E Meyer Zu Schwabedissen; Sibylle Neuhoff
Journal:  Pharmaceutics       Date:  2022-06-29       Impact factor: 6.525

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.